• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Notch-1免疫表达在阿尔茨海默病和皮克病中增加。

Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease.

作者信息

Nagarsheth Mehul H, Viehman Alex, Lippa Sara M, Lippa Carol F

机构信息

Department of Neurology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.

出版信息

J Neurol Sci. 2006 May 15;244(1-2):111-6. doi: 10.1016/j.jns.2006.01.007. Epub 2006 Feb 13.

DOI:10.1016/j.jns.2006.01.007
PMID:16473372
Abstract

Notch-1 is a protein that influences cell fate decisions, with its expression occurring primarily during embryogenesis and development. However, Notch-1 is also expressed in the adult brain, in regions with high synaptic plasticity, particularly the hippocampus. Its role in adults is unknown; however, it may impact neurite outgrowth or cell differentiation in adult brain regions undergoing neurogenesis. Notch-1 is increased in Alzheimer's disease (AD); however, its expression in other CNS degenerative diseases has not been described. To begin to define the range of degenerative disorders where Notch-1 expression is altered, we examined Notch-1 immunoreactivity in a variety of neurodegenerative diseases to determine whether its increase is selective for AD. We examined sections of hippocampus from 13 AD, 13 classical Pick's disease (PiD; with Pick bodies), 4 dementia lacking distinctive histopathology (DLDH) and 8 control brains, emphasizing hippocampal (dentate gyrus) pathology. We determined that Notch-1 immunoexpression is increased in AD and PiD relative to control cases. DLDH cases were not significantly different than control cases with respect to Notch-1 expression. Given the increase in Notch-1 immunoexpression in AD and PiD, two diseases where abnormal tau aggregates are present, and the lack of Notch-1 immunoexpression in DLDH (where tau aggregates are absent), we cannot rule out the possibility that tau aggregates are associated with Notch-1 expression in neurodegenerative diseases.

摘要

Notch-1是一种影响细胞命运决定的蛋白质,其表达主要发生在胚胎发生和发育过程中。然而,Notch-1在成人大脑中也有表达,在具有高突触可塑性的区域,特别是海马体中。它在成人中的作用尚不清楚;然而,它可能会影响正在进行神经发生的成人大脑区域的神经突生长或细胞分化。Notch-1在阿尔茨海默病(AD)中增加;然而,其在其他中枢神经系统退行性疾病中的表达尚未见报道。为了开始确定Notch-1表达发生改变的退行性疾病范围,我们检查了多种神经退行性疾病中的Notch-1免疫反应性,以确定其增加是否对AD具有选择性。我们检查了13例AD、13例经典匹克病(PiD;有匹克小体)、4例缺乏特异性组织病理学的痴呆(DLDH)和8例对照大脑的海马体切片,重点关注海马体(齿状回)病理。我们确定,与对照病例相比,AD和PiD中的Notch-1免疫表达增加。DLDH病例在Notch-1表达方面与对照病例无显著差异。鉴于AD和PiD这两种存在异常tau聚集的疾病中Notch-1免疫表达增加,而DLDH(不存在tau聚集)中缺乏Notch-1免疫表达,我们不能排除tau聚集与神经退行性疾病中Notch-1表达相关的可能性。

相似文献

1
Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease.Notch-1免疫表达在阿尔茨海默病和皮克病中增加。
J Neurol Sci. 2006 May 15;244(1-2):111-6. doi: 10.1016/j.jns.2006.01.007. Epub 2006 Feb 13.
2
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.糖原合酶激酶-3与阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性中的神经元和胶质细胞过度磷酸化tau蛋白沉积有关。
Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13.
3
Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease.转录因子c-Fos、c-Jun、CREB-1和ATF-2以及半胱天冬酶-3的表达与皮克病中异常tau蛋白沉积的关系。
Acta Neuropathol. 2006 Apr;111(4):341-50. doi: 10.1007/s00401-005-0013-0. Epub 2006 Feb 23.
4
Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性患者大脑中tau蛋白微管结合区域的不同免疫反应性及其分子基础。
Acta Neuropathol. 2003 May;105(5):489-98. doi: 10.1007/s00401-003-0671-8. Epub 2003 Feb 8.
5
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.组成型Dyrk1A在阿尔茨海默病、唐氏综合征、皮克病及相关转基因模型中异常表达。
Neurobiol Dis. 2005 Nov;20(2):392-400. doi: 10.1016/j.nbd.2005.03.020.
6
Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice.阿尔茨海默病和 APP 过表达小鼠中 RhoA 的分布改变。
J Alzheimers Dis. 2010;19(1):37-56. doi: 10.3233/JAD-2010-1203.
7
Pick bodies in a family with presenilin-1 Alzheimer's disease.
Ann Neurol. 2005 Jan;57(1):139-43. doi: 10.1002/ana.20366.
8
Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies.阿尔茨海默病和tau蛋白病中Sp1转录因子的异常表达。
Neurosci Lett. 2006;397(1-2):30-4. doi: 10.1016/j.neulet.2005.11.062. Epub 2005 Dec 27.
9
Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.Tau抗血清可识别一系列神经退行性疾病中的神经原纤维缠结。
Ann Neurol. 1987 Oct;22(4):514-20. doi: 10.1002/ana.410220411.
10
Phosphorylation and cleavage of tau in non-AD tauopathies.非阿尔茨海默病性tau蛋白病中tau蛋白的磷酸化与裂解
Acta Neuropathol. 2007 May;113(5):513-20. doi: 10.1007/s00401-007-0209-6. Epub 2007 Mar 15.

引用本文的文献

1
Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases.揭示双特异性酪氨酸磷酸化调节激酶1A抑制剂在阿尔茨海默病中的治疗潜力
Mol Neurobiol. 2025 Mar 5. doi: 10.1007/s12035-025-04806-8.
2
Preclinical Evidence for the Role of the Yin/Yang Angiotensin System Components in Autism Spectrum Disorder: A Therapeutic Target of Astaxanthin.阴阳血管紧张素系统成分在自闭症谱系障碍中的作用的临床前证据:虾青素的治疗靶点
Biomedicines. 2023 Nov 27;11(12):3156. doi: 10.3390/biomedicines11123156.
3
The emerging role of furin in neurodegenerative and neuropsychiatric diseases.
弗林蛋白酶在神经退行性和神经精神疾病中的新兴作用。
Transl Neurodegener. 2022 Aug 23;11(1):39. doi: 10.1186/s40035-022-00313-1.
4
Oncogenic Pathways in Neurodegenerative Diseases.神经退行性疾病中的致癌途径。
Int J Mol Sci. 2022 Mar 17;23(6):3223. doi: 10.3390/ijms23063223.
5
Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review.神经发育障碍中发育途径的分子机制:药理学和治疗学综述。
Open Biol. 2022 Mar;12(3):210289. doi: 10.1098/rsob.210289. Epub 2022 Mar 16.
6
Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization.抑制 CK2 可通过防止 NR2B 突触定位错误来减轻阿尔茨海默病的 Tau 病理。
Acta Neuropathol Commun. 2022 Mar 4;10(1):30. doi: 10.1186/s40478-022-01331-w.
7
Retinal Genomic Fabric Remodeling after Optic Nerve Injury.视网膜基因组结构在视神经损伤后的重塑。
Genes (Basel). 2021 Mar 11;12(3):403. doi: 10.3390/genes12030403.
8
Dual-Specificity Phosphatase 15 (DUSP15) Modulates Notch Signaling by Enhancing the Stability of Notch Protein.双特异性磷酸酶 15(DUSP15)通过增强 Notch 蛋白的稳定性来调节 Notch 信号通路。
Mol Neurobiol. 2021 May;58(5):2204-2214. doi: 10.1007/s12035-020-02254-0. Epub 2021 Jan 8.
9
Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.涉及唐氏综合征患者和非唐氏综合征患者阿尔茨海默病神经退行性变的信号通路。
Int J Mol Sci. 2020 Sep 20;21(18):6906. doi: 10.3390/ijms21186906.
10
A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.公共领域生物信息学资源的协调方法,通过对关键蛋白靶点的专家策展,助力抗击阿尔茨海默病。
J Alzheimers Dis. 2020;77(1):257-273. doi: 10.3233/JAD-200206.